The Tobramycin Study

• Status: Completed
• Trial end date: 2005-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate if tobramycin given once a day is at least as efficacious as the traditional tobramycin given three times a day, given with penicillin G, til patients with febrile neutropenia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Oslo University Hospital
• Collaborators: Sentralsjukehuset i Hedemark; Sentralsjukehuset i Rogaland; Sorlandet Hospital HF; Sykehuset Asker og Baerum; Sykehuset Buskerud; Sykehuset Innlandet HF; The Hospital of Vestfold; The National Institute of Health, Oslo; Ullevaal University Hospital
• Treatments: Tobramycin

Criteria

Febrile neutropenia Cancer Adult (16-70) Signed informed consent